These findings suggest that rapid, early, and potent Spike-directed IgG, IgM, and IgA antibody responses are characteristic correlates that distinguish asymptomatic COVID-19 from COVID-19 with moderate symptoms. The gene discussed is CD40LG; the disease is COVID-19.